Navigation Links
Capsules encapsulated
Date:5/19/2009

This release is available in German.

When cells cannot carry out the tasks required of them by our bodies, the result is disease. Nanobiotechnology researchers are looking for ways to allow synthetic systems take over simple cellular activities when they are absent from the cell. This requires transport systems that can encapsulate medications and other substances and release them in a controlled fashion at the right moment. The transporter must be able to interact with the surroundings in order to receive the signal to unload its cargo. A team led by Frank Caruso at the University of Melbourne has now developed a microcontainer that can hold thousands of individual "carrier units"a "capsosome". As they report in the journal Angewandte Chemie, these are polymer capsules in which liposomes have been embedded to form subcompartments.

Currently, the primary type of nanotransporter used for drugs is the capsule: Polymer capsules form stable containers that are semipermeable, which allows for communication with the surrounding medium. However, these are not suitable for the transport of small molecules because they can escape. Liposomes are good at protecting small drug molecules; however, they are often unstable and impermeable to substances from the environment. The Australian researchers have now combined the advantages of both systems in their capsosomes.

Capsosomes are produced by several steps. First, a layer of polymer is deposited onto small silica spheres. This polymer contains building blocks modified with cholesterol. Liposomes that have been loaded with an enzyme can be securely anchored to the cholesterol units and thus attached to the polymer film. Subsequently, more polymer layers are added and then cross-linked by disulfide bridges into a gel by means of a specially developed, very gentle cross-linking reaction. In the fin
'/>"/>

Contact: Frank Caruso
fcaruso@unimelb.edu.au
61-383-443-461
Wiley-Blackwell
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Video: CREON(R) (Pancrelipase) Delayed-Release Capsules First and Only Pancreatic Enzyme Product to Receive FDA Approval Under New Guidelines
2. KAPIDEX(TM) (dexlansoprazole) delayed release capsules Now Available for the Treatment of GERD
3. Cipher receives tentative FDA approval for extended-release tramadol capsules
4. Mylan Receives Final FDA Approval for Generic Version of Prilosec(R) Delayed-Release Capsules, 40 mg
5. Tiny capsules deliver
6. Mylans Matrix Receives Final FDA Approval for the Generic Version of the Antiretroviral Zerit(R) Capsules
7. Barr Confirms Patent Challenge of Amrix(R) Extended-Release Capsules, 15mg & 30mg
8. Mylan Receives Final FDA Approval for the Generic Version of the Antidepressant Sarafem(R) Pulvules(R) Capsules
9. Watson Launches Omeprazole Delayed-Release Capsules, 40MG
10. Watson Launches Generic MARINOL(R) Capsules
11. Roxane Laboratories, Inc. Announces the Launch of Ramipril Capsules
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... ... August 03, 2015 , ... A July 13 article from The ... Found to Release Natural Painkiller That Can Last 'For Five Weeks'" discusses the ... report, the new study showed that harvesting stem cell-rich bone marrow from the hip, ...
(Date:8/3/2015)... ... August 03, 2015 , ... Illinois Health & Science (IHS) has ... , The acquisition includes all of IBAM NA’s cyclotron sites and research and development ... robust regionally located business, as well as a large manufacturing hub in Noblesville, Indiana,” ...
(Date:8/3/2015)... Ramon, CA (PRWEB) , ... August 03, 2015 ... ... leading global insurance brokerage firm, announced today that Joe Williams has joined its ... development, sales, and delivering HUB's differentiated service model to his clients. Mr. Williams ...
(Date:8/3/2015)... Portland, Ore. (PRWEB) , ... August 03, 2015 ... ... President of Government Programs, with accountability for overall performance of the company’s Medicare ... a key focus of Cambia’s strategy to deliver better health for members. In ...
(Date:8/3/2015)... ... August 03, 2015 , ... ... leading provider of medical information, risk management and investigative services, has introduced ... direction toward focused, expert information solutions that improve business outcomes for its ...
Breaking Medicine News(10 mins):Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 2Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 3Health News:Illinois Health & Science Expands Nuclear Medicine Footprint With Purchase of IBA Molecular North America, Inc. 2Health News:HUB International Insurance Services Announces Joe Williams Has Joined its Northern California Employee Benefits Division 2Health News:Cambia Health Solutions Names Scott Powers President of Government Programs 2Health News:EMSI Announces New Branding: Powerful Information. Improved Outcomes. 2
... Today, in light of a,recent study released by ... April is National STD Awareness Month, Congresswoman Stephanie ... introduced a bi-partisan,resolution urging the House of Representatives ... prevention, screening and treatment of,sexually transmitted diseases (STD)., ...
... Healthcare Realty,Trust Incorporated (NYSE: HR ) today announced ... closes, it will report results for the first,quarter of ... Central Time, Healthcare Realty Trust will,hold a conference call ... Company and industry trends. Simultaneously with,the conference call, a ...
... Awardee to be named at 6th International Stem Cell Symposium Seoul, Korea ... ... SEOUL, Korea, April 22 AlphaMed Press,publisher of the peer-reviewed journal STEM ... the,International Stem Cell Symposium, will be presented on June 20, 2008 in,Seoul, ...
... But doctors want more data, and device not yet approved ... -- A new kind of drug-coated stent was better at ... large-scale U.S. study of the device, researchers report. , "This ... the Xience stent is superior to the Taxus stent, in ...
... VNUS(R) Medical,Technologies, Inc. (Nasdaq: VNUS ), a ... treatment of peripheral vascular disease,explains interruption of its ... p.m. PT/5:00 p.m./ET. As a result of teleconference,vendor ... as planned., Interested parties are encouraged to ...
... parent of a sick child is,emotionally and physically draining. ... a world where there is very little,control and every ... (See video from CIGNA Healthcare at:, http://media.medialink.com/WebNR.aspx?story=34951 ... Leukemia Foundation called the,"Hope Binder" helps parents manage the ...
Cached Medicine News:Health News:Tubbs Jones Introduces Resolution Encouraging STD Prevention 2Health News:Healthcare Realty Trust Announces First Quarter Earnings Release Date and Conference Call 2Health News:Stem Cells(R) and International Stem Cell Symposium Present Annual Stem Cells(R) Young Investigator Award 2Health News:New Drug-Coated Stent Does Well in Early Trial 2Health News:New Drug-Coated Stent Does Well in Early Trial 3
(Date:7/30/2015)... Mettler-Toledo International Inc. (NYSE: MTD ) ... are the highlights: , Sales in local ... prior year. Reported sales decreased 4% as currency reduced ... Net earnings per diluted share as reported (EPS) were ... EPS was $2.80 , an increase of 9% ...
(Date:7/30/2015)... 30, 2015  Tandem Diabetes Care®, Inc. (NASDAQ: ... manufacturer of the t:slim® and t:flex™ Insulin Pumps, ... Development Agreements with Dexcom, Inc. to allow the ... the Dexcom G5 and G6 continuous glucose monitoring ... pump platform with Dexcom,s future CGM systems is ...
(Date:7/30/2015)... and VANCOUVER , July 30, ... announced today that it will report its second quarter ... management will host a conference call and live webcast ... of financial results, clinical development programs and a general ... log on to the Investor Relations page of the ...
Breaking Medicine Technology:Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 2Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 3Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 4Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 5Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 6Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 7Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 8Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 9Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 10Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 11Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 12Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 13Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 14Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 2Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 3
... FSH EIA Test is based ... solid phase enzyme-linked immunosorbent assay. ... monoclonal anti-FSH for solid phase ... anti-alpha FSH in the antibody-enzyme ...
Lyophilized, tri-level assayed human serum-based control, Low, intermediate and high levels, Lot-specific target values provided, Suitable for use with RIA, EIA and chemiluminescent,methodo...
... Hormone (FSH) is intimately involved in the ... of the gonadal tissues, which synthesize and ... The levels of circulating FSH is controlled ... feedback relationship. The FSH Quantitative Test ...
Complete product line for typing all classical HLA loci including A, B, C DRA, DRB1, DRB3, DRB4, DRB5, DQA, DQB1, DPA1, and DPB1....
Medicine Products: